Womens Health - Gowns and Camisoles

Industry News

If you're looking to sell or buy a home in the Essex Connecticut area

If you're interested in real estate in Essex, Centerbrook, Ivoryton, Deep River, Chester, Lyme, Old Saybrook or Westbrook Connecticut, click here to speak to an Essex Village Realtor

>Read More

New Indication Granted for Pfizer's Xalkori for Refractory ALCL

The FDA granted a new indication for crizotinib (Xalkori, Pfizer) for the treatment of pediatric patients aged 1 year and older and young adults with relapsed or refractory, systemic anaplastic large cell lymphoma that is anaplastic lymphoma kinase-positive....

>Read More

What Is Value of Therapeutic Lymph Node Dissection in Melanoma?

Data from a new study indicate a lack of therapeutic benefit for therapeutic lymph node dissection for patients with lymph node recurrences in melanoma....

>Read More

Vogl, NY: Adjuvant CDK Inhibitors--Time for Neither Despair Nor Exultation!

ESMO 2020 saw the presentation of early results from 2 double-blind, placebo-controlled trials examining adjuvant hormonal therapy for resected very high–risk, hormone receptor–positive breast cancer with cyclin dependent kinase (CDK) 4/6 inhibitors or placebo....

>Read More

FDA Approves Orgovyx to Treat Prostate Cancer

The FDA approved relugolix (Orgovyx, Myovant Sciences), the first oral androgen deprivation therapy for adults with advanced prostate cancer....

>Read More

Opioids Can Be Avoided After Most Lumpectomies, Breast Biopsies

New data show that in patients with breast cancer undergoing a lumpectomy or excisional biopsy, nonsteroidal anti-inflammatory drugs and opioids deliver comparable pain control....

>Read More

Tagrisso Approved as First Adjuvant Treatment of EGFR-Mutated NSCLC

The FDA approved osimertinib (Tagrisso, AstraZeneca) for adjuvant therapy after tumor resection in adults with non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor ( EGFR ) exon 19 deletions or exon 21 L858R mutations. ...

>Read More

COVID-19: Great Debates, Sweden and Herd Immunity

One would be hard-pressed to find someone who doesn’t long to return to normal, rather than practicing mitigation strategies against COVID-19, so the idea that natural herd immunity should be allowed to develop is gaining traction in some circles. The virus already is widespread; why not just let herd immunity develop and reduce the threat...

>Read More

Product Listings for Womens Health - Gowns and Camisoles